EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas12a with Antisense Oligonucleotide-Regulated Translational Amplification for Ultrasensitive Nucleic Acid Detection

Yoo-Hong Min, Deok-Gyu Lee, Ha-Yeong Lee, Jin-Hee Yoo, Kyung-Ho Lee, Yong-Beom Shin, Ju-Young Byun iD

ACS Sensors · 2026

DOI: 10.1021/acssensors.5c03081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Yoo-Hong Min und 6 weiteren Autor:innen. Beteiligte Einrichtung: Critical Diseases Diagnostics Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Oligonucleotides, Antisense, Nucleic Acid Amplification Techniques, DNA, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Jeonnam Technopark, Korea Research Institute of Bioscience and Biotechnology, National Research Council of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Highly sensitive nucleic acid testing-assisted early disease detection is crucial for effective disease prevention and management, particularly when targeting low-abundance genetic materials in molecular diagnostics. This study describes CRATE (CRISPR/Cas controlled antisense oligonucleotide (ASO)-mediated translational signal enhancement), a novel ultrasensitive approach for nucleic acid detection by integrating Cas12a trans-cleavage, ASO-controlled gene expression, and cell-free signal protein amplification. This assay leverages the target-induced trans-cleavage of ASO-controlled gene expression for the amplification of signal proteins, with luminescent signal allowing for attomolar-level target DNA detection, as well as antigenic protein application enabling visual detection by lateral flow assay. The CRATE assay improves sensitivity using ASO-modified locked nucleic acid, achieving a 10-aM-level DNA detection. The proof of concept demonstrates 0.1 copies/μL detection of HPV genomic DNA from HPV-positive cancer cells as well as colorimetric lateral flow tests with ∼10 copies/μL sensitivity. The CRATE assay can detect the HBV target in plasma from HBV-positive patients with 100% sensitivity and specificity. With high specificity and accuracy, the CRATE assay retains the potential for detecting any nucleic acid of interest. By integration of precise CRISPR-based cleavage, ASO regulation, and efficient protein signal amplification, this approach provides a promising solution for highly selective and sensitive nucleic acid detection and potential applications in clinical diagnostics and point-of-care testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsOligonucleotides, AntisenseNucleic Acid Amplification TechniquesDNA, ViralEndodeoxyribonucleasesBacterial ProteinsHumansLimit of DetectionCRISPR-Associated Proteins

Stichwörter der Autor:innen

CRISPRantisense oligonucleotidecell-free protein synthesishepatitis B virushuman papillomaviruson-site detection

Substanzen

Oligonucleotides, AntisenseDNA, ViralCas12a proteinEndodeoxyribonucleasesBacterial ProteinsCRISPR-Associated Proteins

Autor:innen und Institutionen

  • Critical Diseases Diagnostics Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
  • Department of Biology, Chungnam National University, Daejeon 305-764, Korea.
  • Department of Chemical Engineering and Applied Chemistry, Chungnam National University, Daejeon 305-764, Korea.
  • Apteasy MJ Inc., 333 Cheomdangwagi-ro, Technopark, Gwangju 61008, Korea.
  • Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.
  • Department of Nanobiotechnology, KRIBB School of Biotechnology, University of Science and Technology, Daejeon 34113, Republic of Korea.

ORCID-Profile: Ju-Young Byun

Förderung

  • Jeonnam Technopark
  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Council of Science and Technology
  • National Research Foundation of Korea

Zitieren

APA

Min, Y. H., Lee, D. G., Lee, H. Y., Yoo, J. H., Lee, K. H., Shin, Y. B., & Byun, J. Y. (2026). CRISPR/Cas12a with Antisense Oligonucleotide-Regulated Translational Amplification for Ultrasensitive Nucleic Acid Detection. ACS Sensors. https://doi.org/10.1021/acssensors.5c03081

Vancouver

Min YH, Lee DG, Lee HY, Yoo JH, Lee KH, Shin YB, et al. CRISPR/Cas12a with Antisense Oligonucleotide-Regulated Translational Amplification for Ultrasensitive Nucleic Acid Detection. ACS Sensors. 2026. doi:10.1021/acssensors.5c03081

BibTeX
@article{Min2026,
  author = {Min, Yoo-Hong and Lee, Deok-Gyu and Lee, Ha-Yeong and Yoo, Jin-Hee and Lee, Kyung-Ho and Shin, Yong-Beom and Byun, Ju-Young},
  title = {CRISPR/Cas12a with Antisense Oligonucleotide-Regulated Translational Amplification for Ultrasensitive Nucleic Acid Detection},
  journal = {ACS Sensors},
  year = {2026},
  doi = {10.1021/acssensors.5c03081}
}
Kostenlos starten →